The $125 billion question: how will the ACA affect cancer survivors?
In 2010, the total cost of cancer care in the United States reached $125 billion. Cancer patients are also living longer today, which is further increasing the cost of their continued care. As the health insurance exchanges have opened and heated debate about the Affordable Care Act (ACA) continues, many questions remain, including the $125 billion question: “How will the ACA affect the most expensive disease: cancer?”
Koblinski joins Massey as a research member
Massey welcomes Jennifer Koblinski, Ph.D., as a research member in the Cancer Molecular Genetics program. Koblinski joined the VCU Department of Pathology as an assistant professor in 2013. Koblinski’s primary research interest focuses on the mechanisms that facilitate breast cancer metastasis to the brain.
Massey researcher leads team to improve data reporting of meningioma treatment outcomes nationwide
A new study led by VCU Massey Cancer Center physician-researcher Leland Rogers, M.D., found that clinical trials to treat the most common primary brain tumor, meningioma, lack uniform guidelines for how physicians should determine whether treatment is effective at shrinking the tumor. The study was published in the Journal of Neurosurgery.
Massey, Tricycle Gardens bring fresh produce to cancer patients
Research continues to show that proper nutrition plays an important role in cancer prevention and control. To help provide cancer patients access to fresh vegetables, VCU Massey Cancer Center has partnered with Richmond-based urban farm Tricycle Gardens to establish a monthly farm stand outside of Massey’s Dalton Oncology Clinic. Additionally, a grant from the McKesson Foundation allows eligible SNAP/EBT participants to receive $2 worth of produce for every $1 of benefits spent on the farm stand produce.
Massey researcher leads task force to develop first guidelines for evaluating and treating children with thyroid cancer
VCU Massey Cancer Center researcher and Children’s Hospital of Richmond at VCU endocrinologist Gary Francis, M.D., Ph.D., recently led a task force commissioned by the American Thyroid Association (ATA) to develop a set of guidelines for evaluating and treating children with thyroid nodules and cancer. The newly issued guidelines are the first and only set of recommendations aimed at managing patients 18 years of age and younger with thyroid tumors and will provide the best practice standards for diagnosing and treating pediatric thyroid cancer.
Massey becomes the only medical provider in Richmond to offer Interleukin-2 therapy
VCU Massey Cancer Center is now offering FDA-approved Interleukin-2 (IL-2) therapy for metastatic melanoma and metastatic renal cell carcinoma, making Massey the only medical provider in the Richmond area to offer this service. IL-2 treatment is a type of immunotherapy that stimulates the body’s immune system to recognize and kill tumor cells.